KINIKSA PHARMACEUTICALS

kiniksa-pharmaceuticals-logo

Kiniksa Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with a significant unmet medical need. It has a pipeline of product candidates across various stages of development, currently focused on autoinflammatory and autoimmune conditions. It has three clinical-stage product candidates, one of which is anticipated to commence a Phase 3 clinical tr... ial in 2018. They follow a disciplined and methodical approach to selectively identify and acquire product candidates with strong biologic rationales or validated mechanisms of action. The company's portfolio of product candidates offers multiple development opportunities. By modulating different parts of the innate and adaptive immune system, these product candidates together have the potential to provide a variety of mechanisms to address multiple devastating diseases.

#SimilarOrganizations #People #Financial #Website #More

KINIKSA PHARMACEUTICALS

Industry:
Biopharma Biotechnology Medical

Founded:
2015-01-01

Address:
Hamilton, Hamilton, Bermuda

Country:
Bermuda

Website Url:
http://www.kiniksa.com

Total Employee:
11+

Status:
Active

Contact:
(781) 431-9100

Email Addresses:
[email protected]

Total Funding:
400 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager Content Delivery Network Domain Not Resolving Nginx Euro Microsoft Exchange Online


Similar Organizations

arrakis-therapeutics-logo

Arrakis Therapeutics

Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.

axispharm-logo

AxisPharm

AxisPharm specializes in ADC drug development, bioconjugation, mass spectrometry, and structure elucidation.

rainier-therapeutics-logo

Rainier Therapeutics

Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.

sirnaomics-logo

Sirnaomics

Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

Current Employees Featured

dana-martin_image

Dana Martin
Dana Martin SVP of Global Medical Affairs @ Kiniksa Pharmaceuticals
SVP of Global Medical Affairs

qasim-rizvi_image

Qasim Rizvi
Qasim Rizvi SVP of Operations and CCO @ Kiniksa Pharmaceuticals
SVP of Operations and CCO

rasmus-holm-jorgensen_image

Rasmus Holm-Jorgensen
Rasmus Holm-Jorgensen Chief Strategy & Portfolio Officer @ Kiniksa Pharmaceuticals
Chief Strategy & Portfolio Officer

thomas-beetham_image

Thomas Beetham
Thomas Beetham EVP of Corporate Development & Operations & CLO @ Kiniksa Pharmaceuticals
EVP of Corporate Development & Operations & CLO

sanjiv-patel_image

Sanjiv Patel
Sanjiv Patel CEO and Chairman @ Kiniksa Pharmaceuticals
CEO and Chairman

arian-pano_image

Arian Pano
Arian Pano Chief Clinical Development Officer, SVP @ Kiniksa Pharmaceuticals
Chief Clinical Development Officer, SVP
2021-03-01

martina-struck_image

Martina Struck
Martina Struck Senior Vice President of Regulatory Affairs @ Kiniksa Pharmaceuticals
Senior Vice President of Regulatory Affairs

chad-morin_image

Chad Morin
Chad Morin Vice President, Chief Compliance Officer @ Kiniksa Pharmaceuticals
Vice President, Chief Compliance Officer
2020-10-01

eben-tessari_image

Eben Tessari
Eben Tessari Chief Operating Officer @ Kiniksa Pharmaceuticals
Chief Operating Officer

melissa-manno_image

Melissa Manno
Melissa Manno Chief Human Resources Officer @ Kiniksa Pharmaceuticals
Chief Human Resources Officer

Founder


sanjiv-patel_image

Sanjiv Patel

Stock Details


Company's stock symbol is NASDAQ:KNSA

Investors List

fidelity-investments_image

Fidelity

Fidelity investment in Series C - Kiniksa Pharmaceuticals

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Series C - Kiniksa Pharmaceuticals

sofinnova-ventures_image

Sofinnova Investments

Sofinnova Investments investment in Series C - Kiniksa Pharmaceuticals

deerfield_image

Deerfield

Deerfield investment in Series C - Kiniksa Pharmaceuticals

baker-brothers-investments_image

Baker Brothers Advisors LLC

Baker Brothers Advisors LLC investment in Series C - Kiniksa Pharmaceuticals

venrock-healthcare-partners_image

Venrock Healthcare Capital Partners

Venrock Healthcare Capital Partners investment in Series C - Kiniksa Pharmaceuticals

arrowpoint-partners_image

ArrowMark Partners

ArrowMark Partners investment in Series C - Kiniksa Pharmaceuticals

baker-brothers-investments_image

Baker Brothers Advisors LLC

Baker Brothers Advisors LLC investment in Series B - Kiniksa Pharmaceuticals

baker-brothers-investments_image

Baker Brothers Advisors LLC

Baker Brothers Advisors LLC investment in Series A - Kiniksa Pharmaceuticals

Official Site Inspections

http://www.kiniksa.com

  • Host name: 151.101.1.193
  • IP address: 151.101.1.193
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Kiniksa Pharmaceuticals" on Search Engine